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Abstract
AIM
To investigate the signaling pathways involved in 
the relaxin (RLX) effects on ileal preparations from 
mice through mechanical and electrophysiological 
experiments.
METHODS
For mechanical experiments, ileal preparations from 
female mice were mounted in organ baths containing 
Krebs-Henseleit solution. The mechanical activity was 
recorded via  force-displacement transducers, which 
were coupled to a polygraph for continuous recording of 
isometric tension. Electrophysiological measurements were 
performed in current- and voltage-clamp conditions by 
a microelectrode inserted in a single smooth muscle cell 
(SMC) of the ileal longitudinal layer. Both the membrane 
passive properties and inward voltage-dependent L-type 
Ca2+ currents were recorded using suitable solutions and 
voltage stimulation protocols.
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RESULTS
Mechanical experiments showed that RLX induced a 
decay of the basal tension and a reduction in amplitude 
of the spontaneous contractions. The effects of RLX 
were partially reduced by 1H-[1,2,4]oxadiazolo[4,3-
a ]-quinoxalin-1-one (ODQ) or 9-cyclopentyladenine 
mesylate (9CPA), inhibitors of guanylate cyclase (GC) 
and adenylate cyclase (AC), respectively, and were 
abolished in the concomitant presence of both drugs. 
Electrophysiological experiments demonstrated that 
RLX directly influenced the biophysical properties of 
ileal SMCs, decreasing the membrane conductance, 
hyperpolarizing the resting membrane potential, 
reducing the L-type calcium current amplitude and 
affecting its kinetics. The voltage dependence of the 
current activation and inactivation time constant was 
significantly speeded by RLX. Each electrophysiological 
effect of RLX was reduced by ODQ or 9CPA, and 
abolished in the concomitant presence of both drugs as 
observed in mechanical experiments. 
CONCLUSION
Our new findings demonstrate that RLX influences ileal 
muscle through a dual mechanism involving both GC 
and AC. 
Key words: Relaxin; Gastrointestinal motility; Smooth 
muscle; AC/cAMP; GC/cGMP 
© The Author(s) 2018. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: Up to now relaxin (RLX) was described to act 
only through the NO/guanylate cyclase (GC)/cGMP/
PKG pathway in different gastrointestinal tracts. The 
results of the present study, achieved on mice ileal 
preparations and carried out by a combined mechanical 
and electrophysiological approach, demonstrate for 
the first time that both GC and adenylate cyclase are 
involved in the effects of RLX in this intestinal region. 
The activation of this dual signaling pathway by RLX 
might represent a reinforcing (redundant) myorelaxant 
mechanism in the ileum, underlying the physiological 
importance of the hormone and leading to speculate 
translational perspectives in the treatment of intestinal 
dysmotilities.
Idrizaj E, Garella R, Francini F, Squecco R, Baccari MC. Relaxin 
influences ileal muscular activity through a dual signaling 
pathway in mice. World J Gastroenterol 2018; 24(8): 882-893 
Available from: URL: http://www.wjgnet.com/1007-9327/full/
v24/i8/882.htm  DOI: http://dx.doi.org/10.3748/wjg.v24.i8.882
INTRODUCTION
It is widely recognized that the effects of the peptide 
hormone relaxin (RLX) are not limited to reproductive 
organs[1-3]. Receptors of the RLX family peptides have 
been indeed identified in both reproductive and non-
reproductive tissues[4-6], including human and rodent 
intestine[7-9]. Concerning on the molecular mechanism 
of action of RLX on the target cells, multiple intracellular 
signaling systems appear to be engaged[10,11]. In some 
cells, such as the smooth muscle of reproductive 
tissue, the effects of the hormone RLX are due to the 
activation of adenylate cyclase (AC)[12-16] leading to 
increase of the cyclic adenosine monophosphate (cAMP) 
levels. However, in some other different preparations, 
such as in vascular and intestinal smooth muscle, the 
mechanism of action activated by RLX occurs through 
the endogenous nitric oxide (NO) synthesis[17-23] and 
leads to increased levels of cyclic guanosine mono-
phosphate (cGMP). 
Particularly, in the gastrointestinal tract of mice, 
RLX has been reported to modulate gastric and colonic 
smooth muscle activity through the L-arginine/NO 
pathway[9,24-26]. NO, synthesized under the catalytic 
action of nitric oxide synthases (NOS)[27], is known 
to cause gastrointestinal relaxation[28] and its altered 
production has been reported to be involved in different 
motor disorders[29]. However, Bani et al[30] raised the 
possibility that in the ileum, at variance with gastric 
and colonic preparations, the NO signaling pathway 
could not be the only one activated by the hormone, 
suggesting the involvement of additional pathways that 
have not been fully elucidated yet in this preparation. 
In this regard, the involvement of AC, in addition to 
guanylate cyclase (GC), in the effects of RLX has been 
reported in rat and guinea pig airways[31] as well as in 
human vascular cells[10]. 
On these grounds, the present study was designed 
to investigate for the first time, if AC/cAMP, besides 
the NO/CG/cGMP, could be a further signaling pathway 
involved in the effects of RLX on ileal smooth muscle. 
To evaluate this possibility, we performed experiments 
by a combined mechanical and electrophysiological 
approach. Particularly, for the first time we investigated 
the ability of RLX to induce changes of smooth muscle 
cell (SMC) biophysical properties in ileal preparations 
through the electrophysiological technique. Moreover, 
we studied the effects of RLX on the L-type Ca2+ current, 
ICa,L, that is supposed to be the main voltage-dependent 
source for Ca2+ entry useful for the activation of the 
SMC contractile machinery[32]. This knowledge may 
contribute to a better understanding of the mechanisms 
engaged by the hormone to modulate intestinal motility 
and may help in the design of further therapeutic 
strategies for the treatment of motor disorders. 
MATERIALS AND METHODS
Animals
Experiments were performed on 8- to 12-wk-old 
female mice (CD1 Swiss strain; Envigo, Udine, 
Italy). The animals were kept under the following 
conditions: 12-h light/12-h dark photoperiod, constant 
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temperature (21 ± 1 ℃), and standard laboratory 
feed. 
After 1 wk of acclimatization, the mice underwent 
assessment of the phase of the estrous cycle by light 
microscopic examination of vaginal smears stained 
with Papanicolaou stain, according to the method of 
Austin and Rowlands[33]. Only mice in proestrus or 
estrus (i.e., the estrogen-dominated phases of the 
ovarian cycle) entered the experiments. This choice 
was made because estrogen is known to favor RLX 
responsiveness of several target organs and tissues[34]. 
The mice were killed by prompt cervical dislocation to 
minimize animal suffering. According to the procedure 
reported in previous paper[30] the mouse abdomen was 
opened, the distal ileum was removed and its content 
was cleaned with a physiological solution.
Mechanical experiments
For the functional studies, segments of the distal ileum 
(within 30 mm from the ileocaecal valve) were isolated 
and placed in Krebs-Henseleit solution, which consisted 
of 118 mmol/L NaCl, 4.7 mmol/L KCl, 1.2 mmol/L 
MgSO4, 1.2 mmol/L KH2PO4, 25 mmol/L NaHCO3, 2.5 
mmol/L CaCl2, and 10 mmol/L glucose pH 7.4, and 
bubbled with 95% O2/5% CO2. Two whole full-thickness, 
transversely cut, ileal segments (10 mm in length) were 
dissected from each animal and placed in 5-mL organ 
baths containing Krebs-Henseleit solution gassed with 
95% O2/5% CO2, while the temperature was maintained 
within a range of 37 ± 0.5 ℃. The preparations were 
mounted in the direction of the longitudinal muscle 
layer and the continuous recording of isometric tension 
was achieved by a force displacement transducer 
(FT03; Grass Instrument) coupled to a polygraph (7K; 
Grass Instrument). The preparations were allowed to 
equilibrate for at least 1 h under an initial load of 1.5 g. 
During this period, the preparations underwent repeated 
and prolonged washes with Krebs-Henseleit solution to 
avoid accumulation of metabolites in the organ baths.
 
Electrophysiological experiments
For electrophysiological recording a full-thickness ileal 
strip was distended and pinned to a Sylgard (Dow 
Corning, Midland, MI, United States)-coated dissecting 
Petri dish filled with Krebs-Henseleit solution. First, 
we pinned the mucosal side up to dissect carefully 
the mucosa and submucosa away under a dissecting 
microscope. The residual tissue was re-pinned serosal 
side up and the connective tissue was removed in 
order to expose the smooth muscle layer. The obtained 
tissue was finally pinned, serosal side up, in the 
recording chamber with a Sylgard floor and a glass 
microelectrodes was inserted in a cell of the longitudinal 
smooth muscle layer. The tissue was continuously 
superfused (Pump 33, Harvard Apparatus) at a rate of 
1.8 mL min-1 with the external solution used. 
Conventional high resistance microelectrodes 
were used according to the previously published 
procedure[9,35]. Microelectrodes were obtained by using 
a micropipette vertical puller (Narishige PC-10) from 
borosilicate glass (GC 100-7.5; Clark) and were filled 
with the following control physiological solution (mmol/L): 
KCl 130, NaH2PO4 10, CaCl2 0.2, EGTA 1, MgATP 5 and 
HEPES/KOH 10. Once filled, the pipette resistance 
measured 60-70 MΩ. The pH was set to 7.4 with NaOH 
and to 7.2 with tetraethylammonium (TEA) hydroxide 
for bath and pipette solution, respectively.
To record RMP in current-clamp and the cell mem-
brane passive properties in voltage-clamp mode 
we used the extracellular Krebs-Henseleit solution. 
To record only Ca2+ currents we bathed the ileal 
muscle strip in a Na+- and K+-free high-TEA solution 
(mmol/L): 10 CaCl2, 145 TEABr and 10 HEPES and 
the microelectrode was filled by the following solution 
(mmol/L): 150 CsBr, 5 MgCl2, 10 EGTA, 10 HEPES. 
Nifedipine (10 μmol/L) was used to block L-type Ca2+ 
current, ICa,L. Heptanol (1 mmol/L) was consistently 
used to block gap junctional currents of the functional 
syncytium and to record membrane passive properties 
and ionic currents elicited only from the impaled 
cell[35,36].
The current amplitude was always normalized to 
cell linear capacitance Cm (in pA/pF) to consent the 
evaluation of test current recorded from cells of different 
size; in fact, Cm is usually  considered an index of cell-
surface area presuming that membrane-specific 
capacitance has a constant value of 1 μF/cm2.
Pulse protocols of stimulation
By using the current clamp mode of our amplifier and 
stimulus waveform with I = 0 pA we recorded the 
SMC resting membrane potential, before and after 
drug stimulation. Protocol of recording consisted of 8 
episodes, having a sampling interval of 20 ms and a 
total duration of 5.29 min. The inter-episode interval 
was 1 min. 
The membrane passive properties, membrane 
conductance (Gm) and Cm, were consistently estimated 
in voltage clamp mode by applying two step voltage 
pulses 75 ms long to -80 and -60 mV starting from a 
holding potential (HP) of -70 mV. Their values were 
calculated as detailed in Squecco et al[37]. Always in this 
mode, ionic currents were evoked by the following pulse 
protocols: ICa,L activation was evoked on the SMC held at 
-80 mV, and 1-s long step pulses were applied in 10-mV 
increments from -70 to 50 mV. For each episode, the 
first 100 ms of the trace had a sampling interval of 
50 μs, and the remaining of 1 s. The interval between 
episodes was 20 s to allow recovery. ICa,L inactivation 
was investigated by a two-pulse protocol with a 1-s pre-
pulse to different voltages followed by 1-s test pulse to 
10 mV as reported in our previous works[9,35]. When we 
applied the two-pulse protocol, we used again a 20-s 
interval between stimulating episodes to allow recovery. 
Capacitive, linear leak and voltage-independent ionic 
currents were cancelled on-line using the P/4 procedure. 
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µmol/L), 1H-[1,2,4] oxadiazolo[4,3-α]-quinoxalin-1-
one (ODQ, 1 μmol/L), 9-cyclopentyladenine mesylate 
(9CPA, 100 μmol/L) and relaxin (RLX, 50 nmol/L). 
All drugs were obtained from Sigma Chemical (St. 
Louis, MO, United States), except for highly purified 
porcine RLX (2500-3000 U/mg) that was generously 
provided by Dr. O. D. Sherwood (University of Illinois, 
Urbana, IL, United States). Solutions were prepared 
on the day of the experiment, except for TTX, for 
which a stock solution was kept stored at -20 ℃. Drugs 
concentrations are given as final bath concentrations. 
The concentration of porcine RLX used was in the range 
of that formerly demonstrated to be effective in murine 
gastrointestinal preparations[9,30,38-40]. The choice of GC 
To evaluate the steady-state ionic current activation 
through the voltage dependent channels we used the 
following equation: 
Ia(V) = Gmax (V-Vrev)/{1 + exp[(Va-V)/ka]} and 
the following was used for the steady-state current 
inactivation: Ih(V) = I/{1 + exp[-(Vh-V)/kh]},  where 
Gmax represents the maximal conductance for Ia; Vrev 
is the apparent reversal potential; Va and Vh are the 
voltages causing the half-maximal activation and 
inactivation, respectively; ka and kh are steepness 
factors. 
Drugs 
We used tetrodotoxin (TTX, 1 μmol/L), nifedipine (10 
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Figure 1  Influence of oxadiazolo[4,3-a]-quinoxalin-1-one and 9-cyclopentyladenine mesylate on relaxin effects on the mechanical activity of the 
mouse ileum. A: Typical tracings showing the spontaneous activity of the ileal segments (Ctr, left hand recordings of each panel).  RLX (50 nmol/L), 30 min from its 
application to the bath medium, causes a decrease in amplitude of the spontaneous contractions and a decay of the basal tension (a, right trace) compared to its 
control (a, left trace). Both these effects are reduced when RLX is added to the bath medium in the presence of 1 µmol/L ODQ (b, right trace) or 100 µmol/L 9CPA (c, 
right trace) and abolished in the presence of ODQ plus 9CPA (d, right trace). Data of each panel (a-d) are obtained from different preparations; B: Bar charts showing 
the influence of ODQ and 9CPA on RLX effects on the mean amplitude of spontaneous contractions (left hand histogram) and basal tension (right hand histogram) 
with respect to the control. All values are means ± SE of 6 preparations from 3 mice. aP < 0.05 vs Ctr; cP < 0.05 vs RLX (one-way ANOVA and Newman-Keuls post-
test); RLX: Relaxin; ODQ: Oxadiazolo[4,3-a]-quinoxalin-1-one; 9CPA: 9-cyclopentyladenine.
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and AC inhibitors was based on previous literature[9,41] 
and their related concentration was in the range of that 
previously proven to be effective[9,42].
Data analysis and statistical tests
As previously reported[30,38], in the mechanical experi-
ments, amplitude of spontaneous contractions and 
variations in basal tension are expressed as grams.
For electrophysiological experiments, mathematical 
and statistical analysis of data was performed by 
SigmaPlot (Jandel Scientific) and pClamp9 (Axon 
Instruments). Statistical analysis was performed by 
Student’s t-test to compare two experimental groups 
or one-way ANOVA followed by Newman-Keuls post-
test for multiple comparisons. The number of muscle 
preparations/cells is designated by n in the results. 
Results are means ± SE. P ≤ 0.05 was considered 
statistically significant.
RESULTS
Mechanical experiments
Effects of relaxin on the mechanical activity: At 
basal tension, ileal preparations (n = 24, from 12 mice) 
showed spontaneous and rhythmic phasic contractions 
(mean amplitude 0.60 ± 0.03 g) (Figure 1), that were 
unaffected by 1 μmol/L TTX (mean amplitude 0.61 ± 
0.03 g), indicating their myogenic nature, and reduced 
by 10 μmol/L nifedipine (0.35 ± 0.05 g).
Addition of RLX (50 nmol/L) to the bath medium 
(n = 18, from 9 mice) caused a clear-cut decay of the 
basal muscle tension (62.3% ± 2.2%) and a reduction 
in amplitude (36.1% ± 1.8%) of the spontaneous 
contractions (Figure 1). The action of the hormone 
on basal tension and on spontaneous activity was 
just evident 10 min and 20 min, respectively, after its 
addition to the bath medium. The influence of RLX on 
ileal motility was long lasting, because its effects could 
still be revealed 1 h after the peptide addition to the 
organ baths (longer time not observed). The effects of 
the hormone on basal muscle tension and spontaneous 
contractions were unaffected by TTX (60% ± 3.1% and 
37.2% ± 1.5%, respectively) whereas they were no 
longer detectable 10 min after the addition of nifedipine 
(P > 0.05 in respect to nifedipine alone) to the bath 
medium.
Addition of the GC inhibitor ODQ (1 μmol/L) to 
the bath medium did not induce significant effects 
(P > 0.05). In the presence of ODQ (1 μmol/L) both 
spontaneous contractions and muscle basal tension 
were only reduced by 50 nmol/L RLX (Figure 1), thus 
suggesting the contribution of other signaling paths in 
the hormone action. We therefore tested the possible 
involvement of the AC pathway, employing the AC 
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Figure 2  Effect of relaxin on smooth muscle cell membrane passive properties and resting membrane potential (RMP) of the mouse ileum. Influence of 
relaxin on Cm (A), Gm (B), Gm/Cm (C) and RMP (D) alone (RLX) or in the presence of ODQ (ODQ + RLX), 9CPA (9CPA + RLX) or both of them (ODQ + 9CPA + 
RLX). aP < 0.05, bP < 0.01, eP < 0.001 vs control SMC (Ctr); cP < 0.05, dP < 0.01, fP < 0.001 vs RLX. In each experimental condition, data are mean ± SE from n = 22 
cells (11 strips from 5 mice) (one-way ANOVA and Newman-Keuls post-test), RLX: Relaxin; ODQ: Oxadiazolo[4,3-a]-quinoxalin-1-one; 9CPA: 9-cyclopentyladenine.
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inhibitor 9CPA (100 μmol/L): 9CPA had not “per se” 
significant effects (P > 0.05) but reduced the actions 
of RLX although it was unable to completely restore 
the control mechanical activity (Figure 1). RLX added 
to the bath medium in the presence of ODQ plus 9CPA 
had no longer effects on both muscle tension and 
spontaneous contractions (Figure 1). 
Electrophysiological experiments 
Influence of relaxin on the smooth muscle 
cell membrane passive properties: To further 
test the possible direct action of RLX on ileal SMC, 
we investigated the effects of the hormone on the 
SMC resting membrane properties. RLX did not alter 
significantly Cm (Figure 2A) but decreased Gm and 
the specific conductance (Gm/Cm) values (Figure 
2B-C). Addition of ODQ (1 μmol/L) or 9CPA (100 
μmol/L) to the external recording medium did not 
affect significantly the membrane passive properties 
compared to the untreated control (P > 0.05). The 
effects of RLX on Gm and Gm/Cm were partially inhibited 
when was added in the presence of ODQ or 9CPA, 
and were completely abolished in their concomitant 
presence, reaching values similar to those observed in 
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control condition (Figure 2B and C). 
Effects of relaxin on smooth muscle cell resting 
membrane potential: We then evaluated the RLX 
effects on resting membrane potential (RMP) of SMCs, 
to test its role on cell excitability. In control condition, 
the membrane potential showed spontaneous irregular 
slow waves (n = 22 cells; 11 strips from 5 mice) (Figure 
3). These waves of the membrane potential lasted 
0.4-1.1 min and showed alternating periods of very 
low (0.5 ± 0.1 wave/min) and higher (1.1 ± 0.2 wave/
min) frequencies lasting 5-6 and 15 min, respectively. 
The maximal hyperpolarization value of the waves was 
considered as the RMP. The mean amplitude of the 
irregular waves was 37.5 ± 8 mV. 
After RLX addition to the bath solution, the irregular 
waves were still recorded but the membrane potential 
showed a hyperpolarization trend that was already 
appreciable 1-3 min after its application (Figure 3A). 
The irregular waves were always recorded during the 
hyperpolarization due to RLX, and maintained a similar 
amplitude, duration and frequency.
The statistical analysis of the RMP values is reported 
as histograms in Figure 2D for each experimental 
condition. Noteworthy, the mean value of control RMP 
was -53.4 ± 7 mV and it reached -91.1 ± 12 mV in 
the presence of RLX, clearly indicating a statistically 
significant hyperpolarization. Furthermore, being the 
size of the irregular wave similar to the control value 
(41.5 ± 8 mV), the positive peak of the waves was 
different in RLX compared to control (Figure 3): it 
reached a mean value of -20 ± 5 (range from -30 to 
-12) mV in control and -49.6 ± 16 (range from -75 
to -25 mV) mV after RLX addition. This observation 
indicates that RLX does not influence the amplitude and 
the frequency of the slow potentials and suggests that 
RLX may hamper the probability to reach a depolarized 
voltage threshold suitable for ion channels activation. 
Consequently, since the slow voltage waves arise from 
a voltage value that is under threshold for the voltage-
dependent L-type Ca2+ current activation (see below) 
and their amplitude in this hyperpolarized state is not 
altered, we could deduce that they are not due to 
voltage-dependent channels opening. 
In order to investigate the possible effectors involved 
in these RLX effects, we used the GC and AC inhibitors 
also in this set of experiments. Again, addition of ODQ 
or 9CPA alone to the external solution did not modify 
significantly the wave amplitude, duration, frequency 
and the resting membrane potential  compared to the 
untreated control (Figure 3) (P > 0.05). RLX added 
at least 5 min after ODQ or 9CPA, hyperpolarized the 
RMP to a lesser extent (Figure 3B and C) compared 
to RLX alone, suggesting the involvement of both GC 
and AC pathways. Once again, in agreement with the 
mechanical results, RLX added in the presence of both 
inhibitors was no more able to induce hyperpolarization 
(Figures 2D and 3D).
Influence of relaxin on the voltage-dependent 
Ca2+ current: The effects of the hormone were 
then evaluated on the inward voltage-dependent 
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Ca2+ currents, supposed to be the chief path for Ca2+ 
entry useful to trigger the contractile machinery in 
intestinal SMCs. Notably, in our experiments we did 
not consistently record TTX-sensitive Na+ current. 
Accordingly, to better put in evidence the appearance 
of voltage-dependent Ca2+ currents, we used 
appropriate filling pipette solution and a bath recording 
high TEA-Ca2+ solution (see Materials and Methods 
section).  The time course of typical current traces 
recorded from a control cell and after RLX addition is 
shown in Figure 4 (Aa and Ab, respectively). Since this 
kind of current had a high voltage threshold (about 
-30 mV), a slow activation and inactivation, and was 
blocked by nifedipine we assumed that it was an 
L-type Ca2+ current (ICa,L). No T-type Ca2+ current was 
revealed in our preparations. It can be clearly seen 
(Table 1, Figures 4A and 5A) that RLX reduced the 
maximal peak current amplitude (P < 0.05) and the 
time to peak (tp) (P < 0.01). Moreover, the hormone 
shifted the mean voltage eliciting the maximal peak 
current size (from 17.5 ± 2 to 20.1 ± 2 mV). 
To evaluate the general behavior of the pheno-
menon, we plotted our experimental data related to all 
the experiments done in the I-V relationship, reporting 
the normalized mean ICa,L maximal amplitude for any 
voltage step applied (Figure 5A). The analysis of the I-V 
plot confirmed that RLX caused the decrease of current 
amplitude and a shift of the Va and Vh values towards 
more positive potential (Table 1). The ODQ or 9CPA pre-
treatment did not completely abolish the effect of RLX, 
but slightly reduced the size decrease (Figure 4) and 
the alteration of the Va and Vh values. These parameters 
completely recovered the control values in the presence 
of ODQ plus 9CPA (Table 1, Figure 5C and D).
The voltage dependence of the current activation 
time constant, τm, (Figure 5C) as well as that of 
inactivation, τh, (Figure 5D) was significantly speeded 
by RLX. Particularly, the ODQ pre-treatment did not 
entirely eliminate the effects of RLX on τm,, that did 
not result significantly different to that recorded in 
the presence of RLX alone, whereas 9CPA resulted 
more effective in counteracting RLX effects (Figure 
5C) which were abolished in the concomitant presence 
of the inhibitors. Instead, the action of RLX on τh was 
similarly prevented by each of the inhibitors (Figure 
5D). 
The effects of RLX and those of the effector 
inhibitors on ICa,L voltage dependence were analyzed 
by the steady-state activation and inactivation curves 
(Figure 5B): RLX shifted the activation and inactivation 
curves towards more positive potentials making this 
latter more U-shaped for depolarized voltages. All the 
Boltzmann parameters were only partially reverted 
to control values when RLX was added after ODQ or 
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9CPA and recovered when the hormone was applied in 
the concomitant presence of both the inhibitors. ODQ 
or 9CPA added alone to the bath solution did not cause 
appreciable differences in current records compared 
to control records (P > 0.05). The best fit parameters, 
statistical analysis and number of analyzed cells are 
reported in Table 1. 
DISCUSSION
The present mechanical and electrophysiological results 
indicate, for the first time, that the hormone RLX is 
able to influence the ileal smooth muscle activity from 
female mice acting through a dual pathway, where both 
CG and AC activity are involved. 
We previously observed in the same kind of pre-
paration[30] that RLX increased the expression of both 
inducible and endothelial nitric oxide synthases but its 
depressant effects were not completely abolished by 
the NO synthesis inhibitor L-NNA. These observations 
indicated that the inhibitory effects of the hormone 
mainly occurred through the activation of intrinsic 
NO biosynthesis but, at the same time, suggested 
the involvement of additional signaling pathways. 
Accordingly, the mechanical results of the present study 
show that the decay of the muscular tension and the 
decrease in amplitude of the spontaneous contractions 
caused by RLX are reduced not only by ODQ but also 
by 9CPA leading to the novel finding that, other than 
GC, AC too is involved in the effects of the hormone 
on ileal motility. The involvement of other signaling 
pathways, besides the NO/cGMP, may account for the 
site-related actions of RLX in the modulation of the 
activity of the different GI tract in mice[26]. In this view, 
regional differences among mouse small intestine 
tracts concerning the nitrergic mechanisms mediating 
inhibitory control of longitudinal SMC contraction have 
been reported: the effects of NO donors were indeed 
completely abolished by ODQ in jejunum but only 
partially eliminated in ileum, suggesting the involvement 
of an additional pathway[43].
Another novel aspect of this research is represented 
by the electrophysiological results demonstrating, for 
the first time in ileal preparations, that RLX was able to 
act directly on the SMC, by influencing its biophysical 
membrane features and the voltage-dependent L-type 
Ca2+ channels properties. Regarding to the biophysical 
properties, the observations that RLX decreases the total 
and specific membrane conductance and hyperpolarizes 
the membrane potential definitely strengthen each 
other, since the decrease of the resting membrane 
conductance can indicate the reduction of aspecific 
cationic influxes that, in turn, hampering the entrance 
of positive charges may favor RMP hyperpolarization. 
They are also in good agreement with the depressant 
mechanical effects observed in this study, since 
changes of the RMP value lead to the reduction of the 
contractile activity that strictly depends on membrane 
potential (electro-mechanical coupling)[44]. However, 
the signaling cascade associated to membrane hyper-
polarization is complicated and still debated; the 
GC/cGMP/PKG- and AC/cAMP/PKA-mediated smooth 
muscle hyperpolarization is also controversial[44-46]. In 
the present experiments, the observation that RLX 
was able to induce hyperpolarization and that both 
ODQ and 9CPA prevented this effect actually supports 
the involvement of GC and AC paths on the RMP 
modulation. 
A remarkable consequence of changes in RMP 
can be relayed on L-type Ca2+ channels activation, 
since a greater depolarization is necessary to reach 
their activation voltage threshold. In this view, it 
could be hypothesized that the rhythmic spontaneous 
slow waves of the membrane potential, mainly due 
to voltage independent channels, only allow a slight 
number of SMC to reach the voltage threshold for 
L-type Ca2+ current, useful for contractile activation 
whereas most of the cells remain relaxed because 
Table 1  Boltzmann parameters of I Ca,L activation and inactivation in a smooth muscle cell in control (Ctr), in the presence of relaxin 
(RLX) alone or RLX with ODQ (ODQ + RLX), 9CPA (9CPA + RLX) and ODQ + 9CPA (ODQ + 9CPA + RLX) 
Parameters Ctr RLX ODQ + RLX 9CPA + RLX ODQ + 9CPA + RLX
ICa,L/Cm (pA/pF)       8.8 ± 0.5        7.2 ± 0.7a       7.9 ± 0.6        8.2 ± 0.6        8.7 ± 0.6c
Vp (mV)  17.5 ± 2 20.1 ± 2  17.9 ± 2   18.1 ± 1    17.5 ± 1.9
tp (ms)  270.8 ± 22   194.1 ± 19b     230.8 ± 15a,c     244.8 ± 22c   259.8 ± 24c
Va (mV)       4.0 ± 0.3        8.9 ± 0.6e          6.0 ± 0.6b,c              4.9 ± 0.5a,d        4.3 ± 0.4d
ka (mV)       6.5 ± 0.4      6.0 ± 0.5       6.2 ± 0.4        6.4 ± 0.4      6.4 ± 0.4
Vrev (mV)  67.2 ± 4 68.8 ± 4  68.1 ± 5   67.5 ± 4 67.8 ± 4
Vh (mV) -14.4 ± 2 -10.9 ± 1a -12.4 ± 1  -12.6 ± 2 -14.0 ± 1c
kh (mV)       7.6 ± 0.5      7.5 ± 0.5       7.6 ± 0.6        7.6 ± 0.7      7.6 ± 0.6
I2h (Norm)      0.09 ± 0.02        0.23 ± 0.02b           0.14 ± 0.01a,d          0.13 ± 0.03d       0.09 ± 0.03f
V2h (mV) 22.0 ± 2    22.3 ± 1.9     21.8 ± 2.1   21.5 ± 2    21.9 ± 1.8
k2h (mV)      8.0 ± 0.7        6.3 ± 0.6a        7.1 ± 0.7          7.5 ± 0.3c        7.9 ± 0.2c
In the U shaped inactivation curves (h) the best fit to the data is obtained by the sum of two Boltzmann terms whose parameters are indicated with the 
subscript h for the term at negative potential, and 2h for the term at positive potential; the amplitude of the normalized second term, I2h (Norm), was 
evaluated at 50 mV. aP < 0.05, bP < 0.01 and eP < 0.001 RLX compared to the related control; cP < 0.05, dP < 0.01 and fP < 0.001 compared to RLX. Data for Ctr 
(  = 67 cells, 25 strips from 12 mice), for RLX (n = 20 cells, 10 strips from 5 mice), for ODQ + RLX (n = 18 cells, 9 strips from 5 mice), for 9CPA + RLX (n = 15 
cells, 8 strips from 5 mice) and for ODQ + 9CPA + RLX (n = 16 cells, 9 strips from 5 mice), RLX: Relaxin; ODQ: Oxadiazolo[4,3-a]-quinoxalin-1-one; 9CPA: 
9-cyclopentyladenine.
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their RMP is too negative for the achievement of the 
electro-mechanical coupling. In fact, the mean positive 
membrane value of the waves observed in the presence 
of RLX resulted significantly more negative than that 
recorded in control condition. Hence, this RLX effect 
could also have a role in the control of RMP when the 
SMC reaches depolarized potentials at which L-type Ca2+ 
channels can be activated: in this case, any reduction 
of Ca2+ influx through membrane channels can facilitate 
the setting of negative charges in the inner side of the 
membrane and thus the hyperpolarization. In addition, 
whenever the channel can be activated, its activation 
would be reduced by RLX, since it also modified its 
voltage-dependence. The consequent reduction of Ca2+ 
influx caused by RLX fits well with its depressant actions 
on the mechanical activity, since L-type Ca2+ channels 
are a chief path through which Ca2+ can enter into the 
cell and trigger the contractile machinery in intestinal 
SMCs. Therefore, their modulation represents an 
effective mechanism playing a role in SMC relaxation. 
Noteworthy, these voltage-gated Ca2+ channels can be 
modulated by several signaling systems such as cyclic 
nucleotides cascades and, even if data about this item 
are sometimes contradictory[47], in general it is accepted 
that cAMP and cGMP inhibit L-type Ca2+ channels. Our 
results actually support this clue in the ileum: L-type 
Ca2+ channels resulted inhibited by RLX treatment 
and either ODQ or 9CPA reduced the effect of RLX, 
thus indicating that RLX exerts its effects through the 
activation of both NO/GC/cGMP and AC/cAMP signaling 
pathways. Since we observed that the blockade of the 
synthesis of each cyclic nucleotide seems to prevent a 
full RLX action also through the other pathway, we also 
suggest a sort of cross-talk mechanism between the 
two pathways, as previously proposed in vascular[44] 
and uterine smooth muscle[48]. 
In conclusion, the bulk of the above results indicate 
that RLX can be considered an efficient intestinal 
motility modulator since it is able to induce significant 
changes in smooth muscle mechanical and electrical 
activity of ileal preparations. In particular, we found 
that RLX reduces the basal tension and the amplitude 
of the spontaneous contractions. These effects fit well 
with the observed decrease of the resting conductance, 
the membrane hyperpolarization and the diminished 
Ca2+ influx through L-type channels. All of these 
actions are exerted by RLX through a dual signaling 
pathway involving both GC and AC, as reported in other 
tissues[10,31]. 
From a physiological point of view, it could be 
speculated that the dual signaling pathway may 
represent a reinforcing and cross-talking (redundant) 
mechanism for RLX aimed to guarantee its actions and 
to prolong its modulatory effects in the small intestine. 
Furthermore, the observation that two pathways are 
engaged by RLX to cause myorelaxation may create the 
basis for identifying new therapeutic targets, offering 
stimulating translational perspectives in the treatment 
of those intestinal dysmotilities characterized by 
hypermotility. 
In conclusion, this study shows for the first time 
that RLX exerts its relaxant effects on ileal smooth 
muscle through the involvement of both GC and AC and 
suggests a cross-talk between GC/cGMP and AC/cAMP 
pathways.
ARTICLE HIGHLIGHTS
Background
Relaxin (RLX) has been reported to modulate gastrointestinal smooth muscle 
activity in mice through the L-arginine/NO pathway. However, the possibility 
that the depressant effects of RLX in ileal preparations could involve additional 
pathways, not fully elucidated yet, was raised. On these grounds, the present 
study was designed to investigate the signaling pathways involved in the effects 
of RLX on ileal preparations. To this aim, we performed experiments using a 
combined mechanical and electrophysiological approach. 
Research frontiers
The actions of RLX occur through a dual signaling pathway that, from a 
physiological point of view, might represent a reinforcing and cross-talking 
mechanism for the hormone aimed to guarantee and to prolong its myorelaxant 
effects in the small intestine.
Innovations and breakthroughs
This study shows, for the first time in ileal preparations, that RLX is able to 
influence the smooth muscle mechanical and electrophysiological activity 
through a dual signaling pathway. 
Applications
The activation of both adenylate cyclase and guanylate cyclase pathways 
by RLX underlines the physiological importance of the hormone to relax ileal 
smooth muscle. In this view, it could be speculated that RLX may represent 
a potential therapeutic tool in those intestinal dysfunctions characterized by 
hypermotility states. 
Terminology
The modulation of gastrointestinal smooth muscle activity by hormones may 
be investigated “in vitro” by recording either the mechanical responses or the 
electrophysiological properties. In ileal preparations, the hormone RLX has 
been shown to exert a modulatory role by depressing spontaneous contractions 
and by influencing the electrophysiological activity.       
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